ChemTrak Inc.

Cholestech Corp. is one of a handful of point-of-care diagnostics companies to carve out a profitable niche for itself, in part because it has been adept at creating a marketing edge. It has made ag

Delisting is the financial equivalent of Siberian exile. You're not dead, but nobody hears from you. And if you want to do anything for yourself while you're there, you're subject to plenty of unreaso

Millennium is turning its business development skills on the diagnostics industry, promising to create a high-margin business for partners and investors in this price-cutter's paradise. by Roger Longm

The sad saga of Oncor Inc. is slowly coming to an end, with the purchase in November of its in situ hybridization business by Ventana Medical Systems Inc. [See Deal] . Ventana paid $5.5 millio